Dozens of NIH study sections — meetings in which panels of expert scientists consider which research projects the agency should support — have been canceled in recent weeks, after the Trump ...

Shares of ORIC opened at $8.03 on Wednesday. ORIC Pharmaceuticals has a 52-week low of $6.33 and a 52-week high of $16.65. The firm’s fifty day moving average is $9.27 and its two-hundred day ...

Smart scales can help you keep track of your muscle mass, body fat percentage, bone density and other health stats — these are the best models we have tested. The best smart scales do far more ...

(RTTNews) - ORIC Pharmaceuticals, Inc. (Nasdaq: ORIC), a clinical-stage oncology company, announced its refined registrational clinical development plans for its lead programs, ORIC-944 and ORIC ...

Forbes contributors publish independent expert analyses and insights. Anna Esaki-Smith is an author and covers higher education.

The American public has consistently supported this life-saving cancer research. The National Institutes of Health (NIH), the main federal agency for medical research, provides about $8 billion in ...

Researchers worldwide who are funded by the US National Institutes of Health (NIH) — the world’s biggest funder of biomedical research — are facing uncertainty about the future of their ...

ORIC Pharmaceuticals outlines clinical development plans for ORIC-944 and ORIC-114, targeting high unmet needs in mCRPC and NSCLC. ORIC Pharmaceuticals has refined its registrational development ...

Pitt receives nearly $700 million in NIH grants, the sixth-highest recipient in the nation and these indirect costs cover things such as lab space and the expensive and sophisticated equipment ...

Colleges receive billions from the NIH to support research. If the proposed rate cuts move forward, institutions say they would have to shut down some labs and lay off employees. “University research ...